Somaxon to Receive Up-front and Milestone Payments of Up to US$129 million Paladin Labs to Purchase US$5 million of Somaxon Common Stock SAN DIEGO & MONTREAL--(BUSINESS WIRE)-- Somaxon Pharmaceuticals ...
MONTREAL, CANADA--(Marketwire - Dec 17, 2012) - Paladin Labs Inc. (PLB.TO) a leading Canadian specialty pharmaceutical company, today announced that Health Canada has approved Silenor® (doxepin ...
Proctor & Gamble and Somaxon Pharmaceuticals have deployed 215 reps in support of Silenor (doxepin), a newly approved sleep aid indicated for sleep maintenance. E-detailing programs will also launch ...
) is reporting after the bell today that the company has entered into a “Professional Detailing Services Agreement” with Publicis Touchpoint Solutions pursuant to which Publicis will provide Somaxon ...
SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (Nasdaq: SOMX), a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded ...
SAN DIEGO, July 19, 2012 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (Nasdaq:SOMX), a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with ...
Somaxon Pharmaceuticals (SOMX) has entered into separate settlement arrangements with Mylan (MYL) and its subsidiary, Mylan Pharmaceuticals, and Par Pharmaceutical Companies and its subsidiary Par ...
Silenor should not be taken with or within two weeks after taking a monoamine oxidase inhibitor (MAOI). Patients should not take Silenor if they have untreated narrow angle glaucoma, if they have ...
Days after raising $65 million in a Series C financing, Somaxon Pharmaceuticals Inc. is kicking off the first of two Phase III trials with lead product Silenor (doxepin), hoping to prove that the ...
Somaxon believes that the FDA’s guidance provides an opportunity to develop an OTC label that is tailored to Silenor’s clinical profile and differentiated from other OTC sleep products. Somaxon ...
Proctor & Gamble and Somaxon Pharmaceuticals have deployed 215 reps in support of Silenor, a newly approved sleep aid indicated for sleep maintenance. E-detailing programs will also launch this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results